PMC · DOI:10.3389/fphar.2025.1650144·July 30, 2025
Editorial: Therapeutic and protective approaches to gastrointestinal tract infections
Roland Bücker
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Species9
Chemicals26
essential oilsPyrazolefidaxomicinnucleosidetenofovirLEOamoxicillinmethicillin4-nitro-3-pyrazolecarboxylic acidentecavirhydroxyapatitelipidoctenidinevitamin Dclarithromycinfatty acidresveratrolmetronidazolebeta-lactam antibioticssimvastatinpyrazolesvancomycinpolyphenolsrosuvastatincarbapenemlevofloxacin
Diseases27
E. coli infectionsautoimmune diseasesgastric cancerCDEUTIchronic infection ofbacterialinfectionvirus infectioncancerinfectious diseasesatherosclerosishepatitis B virus (HBV) infectiongastric and duodenal ulcersacute inflammation indeathinflammatory bowel diseasechronic hepatitis B.gastritisbacterial gastroenteritisvenous thromboembolismacute pyelonephritisgastrointestinal tract infectionsacute renal failurehepatocellular carcinomasystemGram-negative infections
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsClostridium difficile and Clostridium perfringens research · Antimicrobial Resistance in Staphylococcus · Helicobacter pylori-related gastroenterology studies